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Unprocessed interleukin-36α regulates psoriasis-like skin inflammation in co-operation with interleukin-1

Gene
Targeting strategy and validation
IL-36α
Generation initiated at GSK through standard homologous recombination eliminating the mRNA nucleotides 121-263, NM_019450.3. Consequently, part of the 5'UTR and the first 34 codons are absent from the targeted gene (Fig. S1 ). Backcrossed to C57BL/6 4 times at GSK, after which it was transferred to our lab. Backcrossed to C57BL/6 for >6 generations in our lab. IL-36α mRNA levels reduced 30-fold. (Fig.  S2a) . No IL-36α protein, or fragment thereof, detected in skin (Fig. S2b) .
IL-36β
Strain was generated as part of the Knockout Mouse project (KOMP) using a VelociGene KOMP Definitive Null Allele Design ablating the entire Il1f8 coding region, i.e., no mRNA can be expressed. The strain was generated directly on the C57BL/6 background. Phenotypic characterization was not performed by the KOMP.
IL-36γ
Origin: Genentech/Lexicon Pharmaceuticals (repository: MMRRC). The full-length mouse IL-36α protein sequence is shown. Truncated region of the successfully targeted Il1f6 is underlined. Predicted pro-domain of IL-36α is highlighted in blue. Milora, K.A., et al., 2015, J. Invest detection limit. *, P < 0.05; **, P < 0.01; ***, P < 0.001. Milora, K.A., et al., 2015, J. Invest 
